ENO2 and small cell lung carcinoma: Our results showed that RDW can improve the diagnostic ability of Cyfra21-1 and NSE, suggesting that combining the detection of RDW and Cyfra21-1 or NSE may be a better marker for discriminating NSCLC patients from healthy participants or SCLC patients.